Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NCD Evidence Criteria, Public Participation Are Topics Of Future CMS Regs

This article was originally published in The Gray Sheet

Executive Summary

CMS does not plan to publish written criteria for assessing whether a service or item is "reasonable and necessary," HHS acknowledges

You may also be interested in...



Defining “reasonable & necessary”

CMS likely will issue a proposed rule defining the agency's interpretation of its statutory authority to provide coverage, Coverage & Analysis Director Steve Phurrough said Nov. 9 at the Medical Device Manufacturers Association's Reimbursement & Health Policy conference in Washington, D.C. Stakeholders have resisted such a national coverage decision process in the past, he noted (1"The Gray Sheet" May 19, 2006, p. 11)...

Defining “reasonable & necessary”

CMS likely will issue a proposed rule defining the agency's interpretation of its statutory authority to provide coverage, Coverage & Analysis Director Steve Phurrough said Nov. 9 at the Medical Device Manufacturers Association's Reimbursement & Health Policy conference in Washington, D.C. Stakeholders have resisted such a national coverage decision process in the past, he noted (1"The Gray Sheet" May 19, 2006, p. 11)...

Congress Must Develop Cost Criteria For Coverage Decisions – NEJM Article

Legislators should establish "reasonable and necessary" criteria for national coverage decisions that consider cost effectiveness, according to medical ethicist Murial Gillick, MD, Harvard Medical School

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018404

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel